By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Becton Dickinson announced the latest round of winners of its BD Biosciences Research Grant Program. Winners will receive $10,000 worth of research reagents for their projects.

Avantra will identify biomarkers of interest, and MedTrust will engage oncologists in online discussions that will validate the role of different panels in diagnosis, prognosis, and treatment efficacy.

The shipments mark the culimination of a long journey back to market for the platform, which was purchased along with the other assets of defunct firm Decision Biomarkers by Courtagen Capital Group in December 2009.